NEVOID BASAL-CELL CARCINOMA SYNDROME WITH MEDULLOBLASTOMA IN AN AFRICAN-AMERICAN BOY - A RARE CASE ILLUSTRATING GENE-ENVIRONMENT INTERACTION

Citation
Jf. Korczak et al., NEVOID BASAL-CELL CARCINOMA SYNDROME WITH MEDULLOBLASTOMA IN AN AFRICAN-AMERICAN BOY - A RARE CASE ILLUSTRATING GENE-ENVIRONMENT INTERACTION, American journal of medical genetics, 69(3), 1997, pp. 309-314
Citations number
27
Categorie Soggetti
Genetics & Heredity
ISSN journal
01487299
Volume
69
Issue
3
Year of publication
1997
Pages
309 - 314
Database
ISI
SICI code
0148-7299(1997)69:3<309:NBCSWM>2.0.ZU;2-W
Abstract
We present an 8-year-old African-American boy with medulloblastoma and nevoid basal cell carcinoma syndrome (NBCCS) who exhibited the radios ensitive response of basal cell carcinoma (BCC) formation in the area irradiated for medulloblastoma, Such a response is well-documented in Caucasian NBCCS patients with medulloblastoma, The propositus was diag nosed with medulloblastoma at the age of 2 years and underwent surgery , chemotherapy, and craniospinal irradiation, At the age of 6 years, h e was diagnosed with NBCCS following his presentation with a large odo ntogenic keratocyst of the mandible, pits of the palms and soles and n umerous BCCs in the area of the back and neck that had been irradiated previously for medulloblastoma, Examination of other relatives showed that the propositus' mother also had NBCCS but was more mildly affect ed; in particular, she had no BCCs, This case illustrates complex gene -environment interaction, in that increased skin pigmentation in Afric an-Americans is presumably protective against ultraviolet, but not ion izing, radiation, This case and other similar cases in the literature show the importance of considering NBCCS in the differential diagnosis of any patient who presents with a medulloblastoma, especially before the age of 5 years, and of examining other close relatives for signs of NBCCS to determine the patient's at-risk status. Finally, for indiv iduals who are radiosensitive, protocols that utilize chemotherapy in lieu of radiotherapy should be considered. (C) 1997 Wiley-Liss, Inc.